Molecure S.A. (WSE: MOC)
Health Care · Pharmaceuticals · PL
zł6.61
-0.75% today · -10.0% 1Y
Molecure S.A. (WSE: MOC) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $35.02M and employs 102 people.
Over the last twelve months the share price has lost 10.0%, trading between 4.98 and 9.04.
Tweenvest scores Molecure S.A. across four factors: quality 43/100, value 55/100, growth 100/100. Its strongest factor is growth.
MOC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $35.02M
- Revenue (TTM)
- $1.29M
- P/E
- —
- EPS
- -0.64
- Dividend yield
- —
- Beta (5Y)
- 1.00
- 52-week high
- zł9.04
- 52-week low
- zł4.98
- Avg volume (3M)
- —
- Shares outstanding
- 20.60M
- Employees
- 102
- Next earnings
- —
About Molecure S.A.
Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in the research, development, and commercialization of innovative therapies designed to combat neoplastic (cancer) and inflammatory conditions. The company's pipeline prominently features OATD-01, a chitotriosidase/acidic mammalian chitinase inhibitor that has successfully advanced through Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and sarcoidosis. Additionally, Molecure is progressing its YKL-40 program for cancer and fibrosis, OATD-02 for oncology applications, and a Deubiquitinase program. Established in 2012, this Warsaw-headquartered enterprise adopted the name Molecure S.A. in March 2022, having previously been known as OncoArendi Therapeutics S.A.
- ISIN
- PLONCTH00011
- Founded
- 2012
- Listed since
- Apr 19, 2018
- Exchange
- Warsaw Stock Exchange
- Currency
- PLN
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Nippon Chemiphar Co., Ltd.TSE: 4539 | $35.79M | ¥1,564.00 | -0.57% |
| Beit Jala Pharmaceutical CompanyPLSE: BJP | $35.75M | JD— | — |
| Biomind Labs Inc.OTCPK: BMND.F | $35.68M | $— | — |
| Astonea Labs LimitedBSE: 544409 | $35.19M | Rs324.00 | -6.09% |
| Prince Pharmaceutical Co., Ltd.TPEX: 6935 | $33.34M | NT$28.50 | +0.18% |
| Navamedic ASAOB: NAVA | $33.34M | Nkr13.30 | -0.37% |
| ImmuPharma plcAIM: IMM | $33.10M | £0.04 | +21.21% |
| biote Corp.NasdaqGM: BTMD | $32.98M | $1.12 | -2.61% |
Figures last refreshed Oct 11, 2026.